Third Point, or whatever that analyst is on the AMIC website, should not be followed for stock recomendations! They said by mid 2014 with 80% certainty ADMD would have FDA approval. They sure missed that one didn't they! What a joke. I guess we are only one month beyong "mid" but there is just so much news coming out that I kinda think it is not going to happen. Price target of .50 a share if approved, yeah maybe, in another year or so. Hey, I am hanging on to my position but I do have to chuckle a bit about these guys. I have been saying for too long in my opinion that trials would be needed. They are supposed to be in the analyst business but look like they had no clue.
SS, I concur with the fact that a little more, by way of, proof of concept and efficacy, need to take place before AMIC will be allowed to market it's Y-90 Brachytherapy product. It was very naive for Jim and company to think that the FDA would rubber stamp this as a class II on AMIC's first application and AMIC would be off to the races. This though, is where Battelle/PNNL step in, this is their forte. Hopefully by now AMIC. can come back to the table with exactly what the FDA requires to allow AMIC to put this product to use as the new standard of care. MDLAND~
There's a whole lot of shakin' going on this morning. At some point though, even AMIC has to support it's stock price. Hopefully they have a GTC order in to buy a gazillion shares at somewhere just below $.02, just in case. That is, if they're not the ones selling into the market. SS, who knows, your $.019 order might get filled at the rate we're going. MDLAND~